DocWire News (@mydocwire) 's Twitter Profile
DocWire News

@mydocwire

DocWire News delivers the most relevant medical news to over 1M HCPs daily.

ID: 857247500578762752

linkhttps://www.docwirenews.com/ calendar_today26-04-2017 14:58:25

8,8K Tweet

2,2K Followers

2,2K Following

DocWire News (@mydocwire) 's Twitter Profile Photo

πŸ” #Obesity isn't just about choicesβ€”it's a chronic disease. 🧬 It’s time to shift the narrative and treat it with empathy, science, and support. πŸ“– Dive into this eye-opening read: buff.ly/VmVLdf5 #ObesityAwareness #ChronicDisease #HealthcareMatters #EndStigma

πŸ” #Obesity isn't just about choicesβ€”it's a chronic disease.
🧬 It’s time to shift the narrative and treat it with empathy, science, and support.
πŸ“– Dive into this eye-opening read: buff.ly/VmVLdf5

#ObesityAwareness #ChronicDisease #HealthcareMatters #EndStigma
DocWire News (@mydocwire) 's Twitter Profile Photo

🧬 Exciting news in dermatology! Upadacitinib shows promise for treating hidradenitis suppurativa. πŸ“Š In a phase 2 trial, 38.3% achieved HiSCR50 at week 12 vs. 25% with placebo. πŸ”— buff.ly/BEW2lJZ #HidradenitisSuppurativa #Upadacitinib #Dermatology #ClinicalTrials

🧬 Exciting news in dermatology! Upadacitinib shows promise for treating hidradenitis suppurativa.
πŸ“Š In a phase 2 trial, 38.3% achieved HiSCR50 at week 12 vs. 25% with placebo.
πŸ”— buff.ly/BEW2lJZ
#HidradenitisSuppurativa #Upadacitinib #Dermatology #ClinicalTrials
DocWire News (@mydocwire) 's Twitter Profile Photo

🚨 New eczema research is in! πŸ” Find out who benefits most from #lebrikizumab and when. πŸ‘‰ Read more: buff.ly/HOxWrFg #Eczema #Dermatology #Lebrikizumab #HealthNews #SkinCare

🚨 New eczema research is in!
πŸ” Find out who benefits most from #lebrikizumab and when.
πŸ‘‰ Read more: buff.ly/HOxWrFg

#Eczema #Dermatology #Lebrikizumab #HealthNews #SkinCare
DocWire News (@mydocwire) 's Twitter Profile Photo

#ASCO25 πŸš€ 🧬 New research reveals how #organoids provide key insight into #melanoma drug resistance. πŸ§ͺ Could this be a turning point in personalized cancer therapies? πŸ”— buff.ly/vkOLnvQ #CancerResearch #Melanoma #Organoids #DrugResistance #Oncology

#ASCO25 πŸš€  
🧬 New research reveals how #organoids provide key insight into #melanoma drug resistance.  
πŸ§ͺ Could this be a turning point in personalized cancer therapies?  
πŸ”— buff.ly/vkOLnvQ  
#CancerResearch #Melanoma #Organoids #DrugResistance #Oncology
DocWire News (@mydocwire) 's Twitter Profile Photo

#ASCO25 🩺 πŸ“Š New data highlight clinical predictors of early #cutaneousmelanoma recurrence. πŸ“ˆ Key variables may guide post-treatment surveillance and decision-making. πŸ”— buff.ly/dznq8Ka #Melanoma #Oncology #CancerRecurrence #ClinicalResearch #SkinCancer #DermOnc

#ASCO25 🩺  
πŸ“Š New data highlight clinical predictors of early #cutaneousmelanoma recurrence.  
πŸ“ˆ Key variables may guide post-treatment surveillance and decision-making.  
πŸ”— buff.ly/dznq8Ka  
#Melanoma #Oncology #CancerRecurrence #ClinicalResearch #SkinCancer #DermOnc
DocWire News (@mydocwire) 's Twitter Profile Photo

🚨 New research presented at #ASCO25 out of Memorial Sloan Kettering Cancer Center: 🧬 #Papsmear #ctDNA allows for earlier identification of #endometrialcancer πŸ”— Read more: buff.ly/VEiTufb #ctDNA #CancerDetection #EarlyDiagnosis #WomensHealth #MedicalInnovation #LiquidBiopsy

🚨 New research presented at #ASCO25 out of <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a>:
🧬 #Papsmear #ctDNA allows for earlier identification of #endometrialcancer
πŸ”— Read more: buff.ly/VEiTufb
#ctDNA #CancerDetection #EarlyDiagnosis #WomensHealth #MedicalInnovation #LiquidBiopsy
DocWire News (@mydocwire) 's Twitter Profile Photo

πŸ”¬ #ASCO25 πŸ“ˆ Concurrent chemoradiotherapy (CCRT) shows superior outcomes πŸ§ͺ CCRT outperforms radiotherapy and surgery in overall and progression-free survival πŸ’‘ Combining CCRT with other therapies offers comparable efficacy πŸ”— Read more: buff.ly/Cra55Vv

πŸ”¬ #ASCO25
πŸ“ˆ Concurrent chemoradiotherapy (CCRT) shows superior outcomes
πŸ§ͺ CCRT outperforms radiotherapy and surgery in overall and progression-free survival
πŸ’‘ Combining CCRT with other therapies offers comparable efficacy
πŸ”— Read more: buff.ly/Cra55Vv
DocWire News (@mydocwire) 's Twitter Profile Photo

🧬 A new study from #ASCO25 explores neoadjuvant #pepinemab in #headandneckcancer treatment πŸ”¬ Aims to prime #tumor immunity before surgical intervention πŸ“ˆ Potentially enhancing patient outcomes through immune activation πŸ”— Read more: buff.ly/ej6hM9Q

🧬 A new study from #ASCO25 explores neoadjuvant #pepinemab in #headandneckcancer treatment
πŸ”¬ Aims to prime #tumor immunity before surgical intervention
πŸ“ˆ Potentially enhancing patient outcomes through immune activation
πŸ”— Read more: buff.ly/ej6hM9Q
DocWire News (@mydocwire) 's Twitter Profile Photo

πŸ§¬πŸ” New insights into #uterine #leiomyosarcoma! A study presented at #ASCO25 analyzes the genetic profile of LMS using a national database. πŸ“„ Read more: buff.ly/c5D5GES #UterineCancer #GenomicProfiling #CancerResearch #ASCO25

πŸ§¬πŸ” New insights into #uterine #leiomyosarcoma!

A study presented at #ASCO25 analyzes the genetic profile of LMS using a national database.

πŸ“„ Read more: buff.ly/c5D5GES

#UterineCancer #GenomicProfiling #CancerResearch #ASCO25
DocWire News (@mydocwire) 's Twitter Profile Photo

🧬 A new study examines pembrolizumab plus lenvatinib in uterine carcinosarcoma πŸ“Š Results were shared at #ASCO25, highlighting clinical benefit in select patients πŸ”— buff.ly/My4e4f1 #UterineCancer #Immunotherapy #CancerResearch #ASCO25

🧬 A new study examines pembrolizumab plus lenvatinib in uterine carcinosarcoma
πŸ“Š Results were shared at #ASCO25, highlighting clinical benefit in select patients
πŸ”— buff.ly/My4e4f1
#UterineCancer #Immunotherapy #CancerResearch #ASCO25
DocWire News (@mydocwire) 's Twitter Profile Photo

πŸ’Š 71% of patients with sleep disorders preferred solriamfetol over modafinils in a real-world study. πŸ”„ Those who switched back cited better results or fewer side effects with modafinils. πŸ”— Read more: buff.ly/s8IF3HY #SleepHealth #Narcolepsy #Solriamfetol #Modafinil

πŸ’Š 71% of patients with sleep disorders preferred solriamfetol over modafinils in a real-world study.
πŸ”„ Those who switched back cited better results or fewer side effects with modafinils.
πŸ”— Read more: buff.ly/s8IF3HY
#SleepHealth #Narcolepsy #Solriamfetol #Modafinil
DocWire News (@mydocwire) 's Twitter Profile Photo

🧠 REM sleep apnea may be more harmful than we thoughtβ€”it's linked to white matter changes and cognitive decline. 😴 A deeper look into how sleep phases impact brain health. πŸ”— buff.ly/1pUiUSP #SleepHealth #BrainResearch #REM #SleepApnea #Cognition

🧠 REM sleep apnea may be more harmful than we thoughtβ€”it's linked to white matter changes and cognitive decline.
😴 A deeper look into how sleep phases impact brain health.
πŸ”— buff.ly/1pUiUSP
#SleepHealth #BrainResearch #REM #SleepApnea #Cognition
DocWire News (@mydocwire) 's Twitter Profile Photo

πŸŽ₯ Did you know TikTok is reshaping conversations about #irritableboweldisease? 🌍 Patients are turning to social media to connect, learn, & find community. πŸ”— Read more here: buff.ly/r5WJ3ck #IBDAwareness #Crohns #UlcerativeColitis #Healthcare

πŸŽ₯ Did you know TikTok is reshaping conversations about #irritableboweldisease?
🌍 Patients are turning to social media to connect, learn, &amp; find community.
πŸ”— Read more here: buff.ly/r5WJ3ck
#IBDAwareness #Crohns #UlcerativeColitis #Healthcare
DocWire News (@mydocwire) 's Twitter Profile Photo

πŸ₯Ό Mediterranean vs. low-FODMAP: Which diet better supports IBS symptom control in clinical practice? πŸ“Š New comparative data offers insights into efficacy and long-term feasibility. buff.ly/jLV1a6D #IBS #Gastroenterology #MedTwitter #NutritionScience #EvidenceBased

πŸ₯Ό Mediterranean vs. low-FODMAP: Which diet better supports IBS symptom control in clinical practice?
πŸ“Š New comparative data offers insights into efficacy and long-term feasibility.
buff.ly/jLV1a6D
#IBS #Gastroenterology #MedTwitter #NutritionScience #EvidenceBased
DocWire News (@mydocwire) 's Twitter Profile Photo

πŸ‘Ά New study links paternal psychological distress to delays in early child development 🧠 Impacts seen as early as 12 months πŸ’‘ Highlights the need for paternal mental health screening πŸ”— buff.ly/QlZrIRX #ChildDevelopment #MentalHealth #Pediatrics #PublicHealth

πŸ‘Ά New study links paternal psychological distress to delays in early child development
🧠 Impacts seen as early as 12 months
πŸ’‘ Highlights the need for paternal mental health screening
πŸ”— buff.ly/QlZrIRX
#ChildDevelopment #MentalHealth #Pediatrics #PublicHealth
DocWire News (@mydocwire) 's Twitter Profile Photo

🐢 Can dogs help prevent eczema in kids with genetic risk? 🧬 New research says early-life dog exposure may reduce eczema riskβ€”even in those genetically predisposed. πŸ“– Dive into the findings: buff.ly/TAHNxJl #Eczema #Pediatrics #AllergyPrevention #Genetics

🐢 Can dogs help prevent eczema in kids with genetic risk?
🧬 New research says early-life dog exposure may reduce eczema riskβ€”even in those genetically predisposed.
πŸ“– Dive into the findings: buff.ly/TAHNxJl
#Eczema #Pediatrics #AllergyPrevention #Genetics
DocWire News (@mydocwire) 's Twitter Profile Photo

🚨 U.S. FDA has approved #dupilumab for #bullouspemphigoid 🎯 18.3% achieved sustained remission πŸ§ͺ Less steroid use, less itch, better outcomes πŸ”— buff.ly/VtfRuzH #Dermatology #FDAapproval

🚨 <a href="/US_FDA/">U.S. FDA</a> has approved #dupilumab for #bullouspemphigoid
🎯 18.3% achieved sustained remission
πŸ§ͺ Less steroid use, less itch, better outcomes
πŸ”— buff.ly/VtfRuzH
#Dermatology #FDAapproval
DocWire News (@mydocwire) 's Twitter Profile Photo

⚠️ New study links central obesity to higher psoriasis risk πŸ“ Waist circumference may be more telling than BMI 🧬 Highlights need for targeted screening & prevention πŸ”— buff.ly/nPB2jku #Psoriasis #Obesity #Inflammation #Dermatology #ChronicDisease

⚠️ New study links central obesity to higher psoriasis risk
πŸ“ Waist circumference may be more telling than BMI
🧬 Highlights need for targeted screening &amp; prevention
πŸ”— buff.ly/nPB2jku
#Psoriasis #Obesity #Inflammation #Dermatology #ChronicDisease
DocWire News (@mydocwire) 's Twitter Profile Photo

IBD β‰  pneumonia riskβ€”unless other factors are at play. A new study shows comorbidities (12x) and steroid use (2x) are the real drivers of pneumonia in IBDβ€”not the disease itself. buff.ly/TkwsIlY #IBD #InfectionRisk #Pneumonia

IBD β‰  pneumonia riskβ€”unless other factors are at play.

A new study shows comorbidities (12x) and steroid use (2x) are the real drivers of pneumonia in IBDβ€”not the disease itself.
buff.ly/TkwsIlY 
#IBD #InfectionRisk #Pneumonia
DocWire News (@mydocwire) 's Twitter Profile Photo

TikTok skin care for kids may be harmingβ€”not helping. Findings: 🚫 Only 26% used SPF ⚠️ 11+ irritating actives/video 🀳 Often push β€œlighter, brighter” skin ideals Is this beauty or harm disguised as health? buff.ly/2MyPSMF #Skincare #Pediatrics #TikTok

TikTok skin care for kids may be harmingβ€”not helping.

Findings: 

🚫 Only 26% used SPF
⚠️ 11+ irritating actives/video
🀳 Often push β€œlighter, brighter” skin ideals

Is this beauty or harm disguised as health?

buff.ly/2MyPSMF 

#Skincare #Pediatrics #TikTok